StockDuty ← Dashboard Oct 30, 2026 09:14 AM ET
SignalFDA/Bio

AstraZeneca Q3 profit beats estimates as cancer drug sales drive growth

AstraZeneca Q3 profit beat estimates, driven by cancer drug sales growth.

AstraZeneca Q3 profit beat estimates, driven by cancer drug sales growth.
AstraZeneca Q3 profit beat estimates, driven by cancer drug sales growth. — impact context not separately stored; see What changed.
Sources